Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with a median survival of 3-5 years. The aim of the present study was to evaluate disease severity and survival in patients diagnosed with IPF in the era of antifibrotic therapies compared with an earlier IP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyldgaard, Charlotte, Møller, Janne, Bendstrup, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480407/
https://www.ncbi.nlm.nih.gov/pubmed/32944203
http://dx.doi.org/10.1080/20018525.2020.1807682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480407/
https://www.ncbi.nlm.nih.gov/pubmed/32944203
http://dx.doi.org/10.1080/20018525.2020.1807682

Ejemplares similares